| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.58B | 59.34B | 57.01B | 51.94B | 44.80B | 41.96B |
| Gross Profit | 21.83B | 22.62B | 21.80B | 19.10B | 15.26B | 14.85B |
| EBITDA | 11.32B | 11.24B | 11.71B | 9.95B | 7.19B | 6.83B |
| Net Income | 7.58B | 6.83B | 7.83B | 6.58B | 4.51B | 4.10B |
Balance Sheet | ||||||
| Total Assets | 87.01B | 93.29B | 85.00B | 88.04B | 77.53B | 72.05B |
| Cash, Cash Equivalents and Short-Term Investments | 21.66B | 17.43B | 18.67B | 22.73B | 19.33B | 19.13B |
| Total Debt | 8.95B | 8.39B | 2.42B | 2.60B | 3.14B | 3.60B |
| Total Liabilities | 24.56B | 26.44B | 20.71B | 24.13B | 19.84B | 18.06B |
| Stockholders Equity | 59.36B | 63.34B | 60.97B | 61.09B | 55.16B | 51.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.04B | 2.31B | 6.36B | 2.59B | 2.59B |
| Operating Cash Flow | 0.00 | 8.01B | 5.74B | 8.91B | 4.09B | 3.64B |
| Investing Cash Flow | 0.00 | -3.77B | 261.00M | -2.23B | -1.65B | -1.22B |
| Financing Cash Flow | 0.00 | -2.50B | -8.15B | -3.35B | -2.29B | -2.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥88.48B | 12.04 | ― | 3.65% | 4.09% | -7.51% | |
73 Outperform | ¥42.62B | 8.17 | ― | 3.74% | 4.73% | 17.57% | |
70 Outperform | ¥120.37B | 8.88 | ― | 1.92% | 13.77% | 39.53% | |
68 Neutral | ¥123.13B | 10.61 | 12.89% | 3.40% | 3.44% | -3.09% | |
67 Neutral | ¥1.04T | 17.88 | 0.85% | 2.36% | 1.79% | 239.72% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥98.46B | 43.49 | ― | 3.53% | -3.19% | -4.14% |